Home
Finance
Companies
Industry
Market

ALLO

Wall Street Analyst Downgrade Allogene Therapeutics Inc [ALLO]. What else is Wall St. saying

September 19, 2025

Caleb Clifford

Allogene Therapeutics Inc [NASDAQ: ALLO] gained 7.08% on the last trading session, reaching $1.21 price per share at the time. ...

most recent

Finance

BofA Securities lifts CommScope Holding Company Inc [COMM] price estimate. Who else is bullish?

Companies

Perpetua Resources Corp [PPTA] stock Initiated by RBC Capital Mkts analyst, price target now $23

Market

LyondellBasell Industries NV [LYB] is -50.03% lower this YTD. Is it still time to buy?

Finance

CVS Health Corp [CVS] Revenue clocked in at $386.46 billion, up 17.61% YTD: What’s Next?

Industry

Market Analysts see Mosaic Company [MOS] gaining to $45. Time to buy?

Companies

Lucas GC Ltd [LGCL] moved down -25.11: Why It’s Important

Who We Are

At DBT News, we cover what matters locally — with in-depth reporting, contributor perspectives, visual storytelling, and community feedback. Our goal is to keep you informed and engaged through open, respectful dialogue that rises above partisanship.

Quick Links

About Us
Contact Us
Disclaimer
Our Team
Privacy Policy

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

Search for:

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

Enable or Disable Cookies Enabled Disabled